TUMOR AND IMMUNE CELL HETEROGENEITY PRE- AND POST-COMBINED CHEMOTHERAPY AND IMMUNE CHECKPOINT BLOCKADE

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators